At the IGTP TODAY

News

- Research

Study identifies PARG as a new target to enhance chemotherapy in colorectal cancer

A study led by researchers from the Resistance, Chemotherapy and Predictive Biomarkers group at the IGTP, published in Clinical and Translational Medicine, provides new evidence on how to improve the efficacy of one of the most widely used chemotherapy combinations in clinical practice for the treatment of colorectal cancer: 5-fluorouracil and irinotecan (FUIRI).

Translational Program in Cancer Research II Workshop: A hub for research and collaboration

The second CARE Workshop, held on 9-10 October, brought together more than 70 researchers from across the cancer research community at the Can Ruti Biomedical Campus for two days of scientific exchange. The event served as a platform for sharing the current cancer research being developed on the Campus and fostering stronger connections among researchers.

- Research

A new biomarker shows potential to evaluate treatment response for metastatic colorectal cancer

A study led by researchers from the Germans Trias i Pujol Research Institute (IGTP) and Institut Català d’Oncologia (ICO) analysed peripheral blood samples from patients with metastatic colorectal cancer and identified a potential biomarker indicating the effectiveness of oxaliplatin-based treatment. The research has been published in the journal Biomedicine & Pharmacotherapy.

IGTP researchers engage in World Cancer Research Day with talks and workshops

  • In collaboration with the Badalona City Council, a series of events and talks organised to mark the 40th anniversary of the Germans Trias Hospital will deal with topics related to science and health.
  • The event on Sunday at the Badalona Museum is organised by Amics de Can Ruti and will feature researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Catalan Institute of Oncology (ICO).
- Campus Can Ruti

The IGTP hosts the EORTC Pathobiology Group (PBG) Annual Meeting

The European Organisation for Research and Treatment of Cancer (EORTC) Pathobiology Group Annual Meeting took place on October 24 and 25, organized jointly by the Catalan Institute of Oncology (ICO) and the Germans Trias i Pujol Research Institute (IGTP). Over the two-day event, a series of talks on therapies to fight cancer were held both at the IGTP facilities and online.